|
|
Volumn 45, Issue 6, 2001, Pages
|
|
Neuroprotection - Possibilities in perspective
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRIMONIDINE;
GLUTAMIC ACID;
MEMANTINE;
NITRIC OXIDE;
ANTIGLAUCOMA AGENT;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NEUROPROTECTIVE AGENT;
APOPTOSIS;
BLOOD FLOW;
CELL CULTURE;
CLINICAL TRIAL;
DEGENERATIVE DISEASE;
DISEASE COURSE;
EDITORIAL;
GLAUCOMA;
HUMAN;
IMMUNE RESPONSE;
INTRAOCULAR PRESSURE ABNORMALITY;
ISCHEMIC OPTIC NEUROPATHY;
NEUROPROTECTION;
OPTIC NERVE;
OPTIC NERVE DISEASE;
PRIORITY JOURNAL;
RETINA GANGLION CELL;
RETINA ISCHEMIA;
VISION;
CLINICAL RESEARCH;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG USE;
EYE BLOOD FLOW;
FLUORESCENCE;
IMAGE ANALYSIS;
INTRAOCULAR PRESSURE;
MITOCHONDRION;
NEUROIMMUNOLOGY;
NEUROMODULATION;
NONHUMAN;
OPTIC DISK CUP;
RETINA NERVE CELL;
ARTICLE;
CELL SURVIVAL;
DRUG EFFECT;
NERVE CELL;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
APOPTOSIS;
CELL SURVIVAL;
GLAUCOMA;
HUMANS;
NEURONS;
NEUROPROTECTIVE AGENTS;
OPTIC NERVE;
OPTIC NERVE DISEASES;
RETINAL GANGLION CELLS;
|
|
EID: 0034756179
PISSN: 00396257
EISSN: None
Source Type: Journal
DOI: 10.1016/S0039-6257(01)00209-0 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|
